Ortiz-Esquinas Inmaculada, Gómez-Salgado Juan, Pascual-Pedreño Ana I, Rodríguez-Almagro Julián, Martínez-Galiano Juan Miguel, Hernández-Martínez Antonio
Department of Obstetrics & Gynaecology, Alcázar de San Juan, 13600 Ciudad Real, Spain.
Department of Sociology, Social Work and Public Health, University of Huelva, 21071 Huelva, Spain.
J Clin Med. 2019 May 9;8(5):637. doi: 10.3390/jcm8050637.
Clinical practice guidelines recommend the active management of the third stage of labour, but it is currently unknown what practices professionals actually perform. Therefore, the aim of this study was to determine the variability of professional practices in the management of the third stage of labour and to identify any associated professional and work environment factors. A nationwide cross-sectional study was performed with 1054 obstetrics professionals between September and November 2018 in Spain. A self-designed questionnaire was administered online. The crude odds ratios (OR) and adjusted odds ratios (ORa) were estimated using binary logistic regression. The main outcome measures were included in the clinical management of the third stage of labour and they were: type of management, drugs, doses, routes of administration, and waiting times used. The results showed that 75.3% (783) of the professionals used uterotonic agents for delivery. Oxytocin was the most commonly administered drug. Professionals who attend home births were less likely to use uterotonics (ORa: 0.23; 95% confidence interval (CI): 0.12-0.47), while those who completed their training after 2007 (ORa: 1.57 (95% CI: 1.13-2.18) and worked in a hospital that attended >4000 births per year (ORa: 7.95 CI: 4.02-15.72) were more likely to use them. Statistically significant differences were also observed between midwives and gynaecologists as for the clinical management of this stage of labour ( < 0.005). These findings could suggest that there is clinical variability among obstetrics professionals regarding the management of delivery. Part of this variability can be attributed to professional and work environment factors.
临床实践指南推荐对第三产程进行积极管理,但目前尚不清楚专业人员实际采用何种做法。因此,本研究的目的是确定第三产程管理中专业做法的差异,并识别任何相关的专业和工作环境因素。2018年9月至11月在西班牙对1054名产科专业人员进行了一项全国性横断面研究。通过在线方式发放自行设计的问卷。使用二元逻辑回归估计粗比值比(OR)和调整比值比(ORa)。主要结局指标纳入第三产程的临床管理,包括:管理类型、药物、剂量、给药途径和使用的等待时间。结果显示,75.3%(783名)专业人员在分娩时使用宫缩剂。催产素是最常用的药物。在家中接生的专业人员使用宫缩剂的可能性较小(ORa:0.23;95%置信区间(CI):0.12 - 0.47),而2007年后完成培训的专业人员(ORa:1.57(95%CI:1.13 - 2.18))以及在每年接生超过4000例的医院工作的专业人员(ORa:7.95 CI:4.02 - 15.72)使用宫缩剂的可能性更大。在助产士和妇科医生之间,这一产程的临床管理也存在统计学显著差异(<0.005)。这些发现可能表明,产科专业人员在分娩管理方面存在临床差异。这种差异部分可归因于专业和工作环境因素。